Subscribe Now
Forgot Password?

Weekly News, Analysis, and Commentary

Company News Feature

FLXfit / Courtesy of Expanding Orthopedics, Inc.

EOI: First Implantation of FLXfit in New Jersey

Elizabeth Hofheinz, M.P.H., M.Ed. • Wed, February 3rd, 2016

Print this article

Expanding Orthopedics, Inc. (EOI) has announced that Jonathan Lewin, M.D. of North Shore Forest Hills Hospital in New York is the first surgeon in New Jersey to adopt the FLXfit articulated and lordotic expandable cage as his choice of treatment for MIS TLIF (transforaminal lumbar interbody fusion) surgery.

Dr. Lewin, director of spine surgery at North Shore Forest Hills Hospital and director of the Center for Musculosketal Disorders in Englewood, New Jersey, stated in the February 1, 2016 news release, "I was immediately impressed by the FLXfit's immense footprint and was excited to finally be able to insert a big cage from the back through a MIS single portal incision. The FLXfit is the only cage available on the market that dials in lordosis within the disc space. This enables us to offer every patient a customized implant that will adapt to the patient's unique anatomy and provide the best possible fit and stability."

Dr. Lewin added, "We are excited to adopt advanced new technologies for MIS [minimally invasive spine] surgery as we have expanded our practice with the addition of Dr. Seth Grossman and Dr. Vigmin Vora to cope with the increased demand for our services. Our goal is to become one of the leading MIS spine surgery teams in New Jersey. The adoption of such unique MIS technologies enables us to offer our patients the best possible treatment options leading to faster recovery."

Ofer Bokobza, CEO of Expanding Orthopedics, said, "We are excited to collaborate with Dr. Lewin and his team and congratulate them for joining a growing list of spine surgeons selecting the FLXfit as their new standard of care."

Dr. Lewin told OTW, “I was very impressed with the enormous footprint of the cage as well as its lordotic features. We have been searching for an expandable device to rival the ALIF in a minimally invasive context. We believe this device has tremendous potential to achieve interbody fusion, while minimizing surgical trauma. The company is to be congratulated for its attention to surgeon need and detail.”

Send to a Friend

The article link will be sent to the email address you provide

Your Name (required)

Your Email (required)

Friend's Email (required)

Comments

Leave a Reply

Name

Email Address (will not be published)

Website

Comment: